Investigating the Effects of the "GameDay Ready" Behavioral Weight Management Program for Black Men Living in the Rural South
Launched by UNIVERSITY OF SOUTH CAROLINA · Jul 24, 2023
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new 12-week weight management program called "GameDay Ready," specifically designed for Black men living in rural areas of South Carolina who are dealing with obesity. The goal is to see if this program can help participants lose more weight compared to a traditional walking and health education program. Researchers hope that those who join the "GameDay Ready" program will experience greater weight loss and improve their overall health.
To be eligible for this study, participants must be self-identified African American or Black men aged 25 to 65 with a body mass index (BMI) between 27 and 50. They should also have lived in a rural area for at least a year and be able to understand and speak English. Participants will be randomly assigned to either the "GameDay Ready" program or the comparison group. It’s important to note that those with certain health conditions or who are currently in other weight loss programs may not be eligible unless they have specific approval from their healthcare provider. If you decide to participate, you can expect to be part of a supportive program aimed at helping you achieve your weight loss goals over the next three months.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Self-identified African American or Black American male
- • 25-65 years of age
- • BMI 27kg/m2 to ≤50kg/m2 (those with a BMI \>45 will need documented approval by a healthcare provider to participate in the study)
- • Live in a rural area of South Carolina and have lived in a rural area for at least 1 year
- • Able to speak and understand English
- • Willing to be randomized to the intervention or comparison program
- Exclusion Criteria:
- • Positive response to any question on the Physical Activity Readiness Questionnaire (PAR-Q) (Participant may be included if approval is provided and documented by a healthcare provider)
- • Currently participating in another weight loss trial or program or have participated in a trial or program within 6 months prior to starting the intervention
- • Uncontrolled hypertension (systolic blood pressure ≥160 mm Hg or diastolic blood pressure ≥100 mm Hg), diabetes, or asthma (Participant may be included if approval is provided and documented by a healthcare provider)
- • Pulmonary disease requiring supplemental oxygen or daily use of short-acting bronchodilators
- • Any musculoskeletal condition that would preclude meeting recommended levels of moderate-to- vigorous physical activity
- • Within 30 days prior to participating in the study, have taken prescription or nonprescription medications, herbals, or supplements for weight loss
- • On special diet for a serious health condition (does not include general dietary advice from a healthcare provider for common risk factors such as hypertension, diabetes, or hyperlipidemia).
- • Major surgery in the past 6 months
- • Have undergone weight loss surgery or considering weight loss surgery within the next 6 months
- • Have been treated for cancer in the past 12 months (other than non-melanoma skin cancer)
- • Weight loss ≥5% during the past 6 months
- • Plans to move to another county in the next 6 months
- • Any other perceived physical or mental health-related condition that would preclude participating in a behavioral program designed to promote weight loss
About University Of South Carolina
The University of South Carolina (USC) is a leading research institution dedicated to advancing healthcare through innovative clinical trials and studies. With a commitment to excellence in research and education, USC leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical investigations aimed at improving patient outcomes and addressing pressing health challenges. Collaborating with a diverse network of healthcare professionals, researchers, and community partners, USC fosters an environment of discovery and translation, ensuring that findings from clinical trials contribute significantly to the advancement of medical science and evidence-based practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbia, South Carolina, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported